Shokouhi Shervin, Niyati Raziyeh, Darazam Ilad Alavi, Gachkar Latif, Goharani Reza, Kahkoue Shahram
Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti, University of Medical Sciences, Tehran, Iran.
Department of Critical Care, Imam Hussein Educational Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Infect Disord Drug Targets. 2018;18(1):23-28. doi: 10.2174/1871526517666170505122057.
Chest Radiograph accompanied by clinical and laboratory findings are required for diagnosis and follow-up of patients with suspected ventilatorassociated pneumonia (VAP). However, there are no reliable data whether follow-up chest-X-ray (CXR) is needed or not, moreover, when the physicians request CXR and how many times CXR is required. We aimed to determine association of the clinical improvement with resolution of pulmonary infiltrates as well as time of resolution.
The patients with a diagnosis of VAP based on Clinical Pulmonary Infection Score (CPIS) were enrolled in this study. Clinical evaluation and follow-up were continued and CXR was performed sequentially in two-day intervals until clinical improvement or occurrence of other events including death. Fischer test was used to analyze the association of clinical improvement with radiographic resolution.
Out of the seventy -five patients, pneumonia was clinically improved in 48 cases. Mean duration of the clinical improvement was 5.3±4.5 days. Among these patients, pulmonary infiltrations in 44 patients were resolved completely (13.8±5.8 days). Twentyseven patients had no clinical improvement and all of them revealed no infiltration resolution according to the sequential imaging studies. Resolution of radiographic involvement significantly was associated with clinical improvement (p=0.000).
Radiographic resolution occurs in most of patients who survived VAP and there is strong relationship between radiographic resolution and clinical improvement. Moreover, our data revealed that CXR clearance occurred earlier than anticipated previously. Thus, sequential follow-up CXR in VAP had no further clinical value.
对于疑似呼吸机相关性肺炎(VAP)患者的诊断和随访,需要胸部X光片以及临床和实验室检查结果。然而,对于是否需要进行随访胸部X光检查(CXR),以及医生何时要求进行CXR以及需要进行多少次CXR,目前尚无可靠数据。我们旨在确定临床改善与肺部浸润消散之间的关联以及消散时间。
本研究纳入了根据临床肺部感染评分(CPIS)诊断为VAP的患者。持续进行临床评估和随访,并每隔两天依次进行CXR,直至临床改善或出现包括死亡在内的其他事件。采用Fischer检验分析临床改善与影像学消散之间的关联。
在75例患者中,48例患者的肺炎临床症状得到改善。临床改善的平均持续时间为5.3±4.5天。在这些患者中,44例患者的肺部浸润完全消散(13.8±5.8天)。27例患者临床症状未改善,根据连续影像学检查,所有患者均未出现浸润消散。影像学受累的消散与临床改善显著相关(p = 0.000)。
大多数VAP存活患者出现了影像学消散,影像学消散与临床改善之间存在密切关系。此外,我们的数据显示CXR清除比之前预期的更早发生。因此,VAP患者的连续随访CXR没有进一步的临床价值。